Days of prophylactic filgrastim use to reduce febrile neutropenia in patients with non-Hodgkin's lymphoma treated with chemotherapy.

Journal of managed care pharmacy : JMCP

Volumn 9, Issue 2 Suppl, 2003, Pages 15-21

  Scott, Shane D ^a   Chrischilles, Elizabeth A ^a   Link, Brian K ^a   Delgado, David J ^a   Fridman, Moshe ^a   Stolshek, Bradley S ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHOP PROTOCOL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG USE; FEMALE; FEVER; HUMAN; MALE; NEUTROPENIA; NONHODGKIN LYMPHOMA; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION REVIEW; FEMALE; FEVER; FILGRASTIM; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; NEUTROPENIA; PREDNISONE; TREATMENT OUTCOME; VINCRISTINE;

MLCS; MLOWN;

EID: 0142240826     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2003.9.s2.15     Document Type: Article

References (0)